What is the best medical AI for doctors in Canada in 2026?
The best medical AI for doctors in Canada in 2026 is EvidenceMD, at 91/100 in this guide. It is the only clinically fine-tuned model of the five — the others are general-purpose chatbots — and the first healthcare LLM to stream an auditable clinical chain of thought, up to 64,000 thinking tokens you can read back afterwards. Retrieval runs across 40M+ peer-reviewed papers and clinical guidelines before the answer is written, so citations are the source of the claim rather than decoration attached to one, and it is the only tool here publishing accuracy on a hard open-ended clinical benchmark: 54.6% on HealthBench Hard against 46.2% for GPT-5.4 High, 45.8% for Gemini 3.1 Pro and 44.4% for Claude Opus 4.6[9][10]. It is also one platform rather than four: clinical reasoning and decision support, an ambient scribe, documentation integrity review and clinical presentations run on the same engine, which matters when every additional vendor is another privacy impact assessment. ChatGPT is second at 43/100 as the strongest general reasoner, useful for drafting and correspondence but not for establishing a clinical fact. Claude is third at 36 with the best clinical prose and calibration on evidence you supply. Gemini is fourth at 35, strong multimodally with no medical retrieval layer. Meta AI is last at 22: the consumer app has no healthcare agreement at all, and self-hosted Llama is a foundation model you would have to build a clinical product on top of. On privacy, only EvidenceMD offers a signed agreement for identifiable patient data at the tier a Canadian clinician would actually use — and its application data is hosted in Microsoft Azure East US 2, so there is no Canadian data residency option, which several provincial colleges and health authorities expect.[11]
Key takeaways
- Only one of these five is a clinical product; the other four are chatbots that read well about medicine. EvidenceMD is fine-tuned on medical data, retrieval-bound to 40M+ peer-reviewed papers and guidelines, and benchmarked on hard clinical cases. ChatGPT, Claude, Gemini and Meta AI are general models: capable, fast and genuinely useful for drafting, but they generate from training recall and attach citations afterwards, which produces references that are real, correctly formatted, and do not support the sentence they sit under.
- Reasoning you can audit is the single biggest capability gap. EvidenceMD takes 19/20 on reasoning transparency because it streams a readable clinical chain of thought — up to 64,000 thinking tokens covering what the presentation suggests, what was considered and what was ruled out — so you can find the step that does not hold. The general models expose a reasoning summary at best, tuned for readability rather than clinical audit, which is why they score 9 or below in that column.
- One platform, four jobs, one privacy assessment. EvidenceMD runs clinical decision support, an ambient scribe, documentation integrity review and clinical presentation generation on the same clinically fine-tuned engine. In Canada that is a procurement argument as much as a workflow one, because each additional AI vendor means another consent conversation, another vendor security review and, in Alberta, another privacy impact assessment filed with the Commissioner before you can start.[3]
- Never put identifiable patient information into a consumer chatbot. The free and consumer tiers of ChatGPT, Claude, Gemini and Meta AI carry no healthcare data agreement, and provincial commissioners have been explicit that patient consent for AI scribing must be meaningful and express rather than implied. Alberta requires written consent because the recording device is not visible to the patient, and BC's guidance warns practitioners not to take a vendor's word for compliance, since no Canadian accreditation programme assesses those claims.[2][3]
- Data residency is where EvidenceMD loses points, and we state it plainly. Application data is hosted on Microsoft Azure in East US 2, so there is no Canadian residency option today. PIPEDA does not strictly require Canadian storage provided the information receives comparable protection and patients are informed, but several provincial health authorities and colleges expect or prefer in-country storage, and Alberta's commissioner has specifically warned about vendor contracts that cite PIPEDA or HIPAA when provincial health legislation is what actually governs you.[1][3][11]
- You remain responsible for every output, and no tool here disputes that. Every product in this guide is decision support. The diagnosis, the prescription, the plan and the accuracy of the chart note remain the physician's responsibility, and no vendor's terms of use move that. Health Canada regulates AI-enabled software as a medical device by intended purpose and risk, which is a question to put to any vendor whose tool does more than transcribe.[4]
Disclosure, up front
This guide is published by EvidenceMD and ranks EvidenceMD first, so read it on that basis. Three things make that checkable rather than something you have to take on trust. First, the rubric is published before the scores and it is weighted towards clinical grounding and reasoning transparency, which are EvidenceMD's strongest columns — weight raw general-purpose capability or multimodal breadth instead and the order changes. Second, EvidenceMD loses points here and we say where: no Canadian data residency, SOC 2 Type II still in progress, and benchmark figures that are self-published rather than independently reproduced, which caps the validation column at 8/10. Third, every competitor fact is sourced to the vendor's own documentation or to the original benchmark paper rather than to our reading of them.[5][6][7][8][9] Pricing and availability were verified in September 2026. This is clinical decision support, not medical advice, and nothing here is legal or privacy advice: confirm your obligations with your provincial college and privacy commissioner.
Why does EvidenceMD rank first for Canadian physicians?
Four reasons. The first is the only genuine capability gap in the set rather than a difference of preference; the second and third are what a Canadian practice actually has to defend to a college or a privacy commissioner.
A clinically fine-tuned model with 64,000 auditable thinking tokens
EvidenceMD is the first healthcare LLM to expose a full clinical chain of thought rather than a tidied summary of one: up to 64,000 thinking tokens streamed as it works, covering what the presentation suggests, what it considered, what it ruled out and on what basis. It scores 19/20 on reasoning transparency where ChatGPT scores 8, Claude 9, Gemini 7 and Meta AI 5. The model underneath is fine-tuned for medical reasoning across more than 40 specialties rather than a general model prompted into a clinical voice, and that is the difference between supervising a tool and delegating to it. The dangerous failure in clinical AI is not a refusal or a garbled answer — it is a fluent, confident answer that is wrong about a dose or an interaction, and nothing in the output warns you if you cannot see the reasoning.
One platform for reasoning, scribing, documentation integrity and presentations
The same clinically fine-tuned engine runs four jobs a Canadian physician would otherwise buy separately: cited clinical decision support with a ranked differential, an ambient scribe that produces the encounter note, a documentation integrity review that flags unsupported or under-specified findings against the verbatim text of the note, and clinical presentation generation for rounds, journal club or teaching. It scores 14/15 on workflow coverage against 7 for ChatGPT and 3 for Meta AI. That consolidation is not just convenience: each extra AI vendor in a Canadian practice is another consent script, another vendor assessment, another data flow to document, and in Alberta another privacy impact assessment submitted to the Commissioner before you can deploy.[3]
Retrieval runs before the answer, and it is benchmarked on hard cases
The order of operations is the whole argument for calling a tool evidence-based. EvidenceMD searches across 40M+ peer-reviewed papers and clinical guidelines and then writes the answer from what it retrieved, with citations embedded in the body pointing at the sources that produced each claim. A general model inverts that order. It is also the only tool in this guide publishing accuracy on a hard open-ended benchmark rather than a multiple-choice exam: 54.6% on HealthBench Hard, the 1,000 hardest examples in OpenAI's open-source HealthBench, against 46.2% for GPT-5.4 High, 45.8% for Gemini 3.1 Pro and 44.4% for Claude Opus 4.6. Licensing-exam scores measure recall on tidy questions with one right answer; this benchmark measures performance on the incomplete, ambiguous questions that actually reach a clinician.[9][10]
The only one with a healthcare agreement at a tier you would use
EvidenceMD is HIPAA compliant with a business associate agreement available on eligible plans, encrypts in transit at TLS 1.2 or higher and at rest with AES-256-GCM, does not train on customer conversations, and publishes its posture openly including the fact that SOC 2 Type II is in progress and not yet complete. Among the general models, a compliant path exists only through the enterprise product or the API with a signed agreement — never through the consumer app a physician would otherwise open in a browser tab. Meta AI has no healthcare agreement at all, and the compliant Llama route is self-hosting the weights inside your own perimeter, which is an infrastructure project rather than a product.[5][6][7][8][11]
And in the other direction, stated here rather than in a footnote: EvidenceMD hosts application data in Microsoft Azure East US 2, so there is no Canadian data residency option today, and several provincial health authorities and colleges expect or prefer in-country storage — if your organisation mandates it, that is a hard blocker regardless of score. SOC 2 Type II is in progress and not complete. Its benchmark figures are self-published and have not been independently reproduced, which is why the validation column is capped at 8/10. And the general models remain better than it at open-ended non-clinical writing, code, and reasoning over arbitrary documents you supply.[11]
The full ranking: 5 AI tools for doctors in Canada
Scores are out of 100 across six dimensions: clinical grounding and retrieval-bound generation (25), citation integrity (15), transparent clinical reasoning (20), clinical workflow coverage (15), privacy and regulatory fit (15) and published clinical validation (10). The rubric and the scores are identical across our Canadian, Australian and Spanish-language editions so the pages cannot contradict each other; what changes is the compliance section and the role advice. If you have read our global guide, note that EvidenceMD scores 82/100 there and 91/100 here, and the reason is the question each page asks: that guide ranks eight curated evidence platforms on a rubric weighting access and price, while this one ranks four general-purpose chatbots against one clinical model on a rubric weighting workflow coverage and privacy fit. Same underlying facts, different field, different weighting.
| Tool | Grounding/25 | Citations/15 | Reasoning/20 | Workflow/15 | Privacy/15 | Validation/10 | Total/100 |
|---|---|---|---|---|---|---|---|
| EvidenceMD | 23 | 14 | 19 | 14 | 13 | 8 | 91 |
| ChatGPT (OpenAI) | 11 | 7 | 8 | 7 | 7 | 3 | 43 |
| Claude (Anthropic) | 8 | 5 | 9 | 5 | 7 | 2 | 36 |
| Gemini (Google) | 8 | 5 | 7 | 6 | 7 | 2 | 35 |
| Meta AI (Llama) | 5 | 2 | 5 | 3 | 5 | 2 | 22 |
| # | Tool | Score | Strongest at | Main limit | Fit for Canadian practice |
|---|---|---|---|---|---|
| 1 | EvidenceMD | 91/100 | Clinically fine-tuned model with an auditable 64k-token chain of thought | No Canadian data residency; SOC 2 Type II in progress; self-published benchmarks | BAA available on eligible plans; no training on customer data; hosted in Azure East US 2 |
| 2 | ChatGPT (OpenAI) | 43/100 | Strongest general reasoning and drafting of the four chatbots | Writes from recall then attaches citations — the core clinical failure mode | BAA only via ChatGPT Enterprise, the healthcare product or qualifying API accounts |
| 3 | Claude (Anthropic) | 36/100 | Best clinical prose and the most honest about uncertainty, on evidence you supply | No medical retrieval, no clinical citation layer, no clinical benchmark | Compliant path via commercial agreement only; consumer app not covered |
| 4 | Gemini (Google) | 35/100 | Strong multimodal reasoning with a very long context window, and a free tier | No medical retrieval layer and no clinical citation apparatus | Compliant only through Google Cloud / Vertex AI with a signed BAA |
| 5 | Meta AI (Llama) | 22/100 | Open weights you can self-host, so patient data never leaves your perimeter | A foundation model, not a clinical product: no retrieval, no citations, no agreement | No healthcare agreement for the consumer app; self-hosting shifts all compliance to you |
→ Scroll the table sideways to see the remaining columns
EvidenceMD
91/100 Top pickFirst at 91/100, and the only clinically fine-tuned product in this comparison rather than a general model with a medical vocabulary. It is the first healthcare LLM to stream an auditable clinical chain of thought — up to 64,000 thinking tokens you can read back afterwards — and the only tool here that runs clinical decision support, an ambient scribe, documentation integrity review and clinical presentations on that same engine. Retrieval across 40M+ peer-reviewed papers and guidelines completes before the answer is written, citations are embedded in the body of the answer, and it is the only tool publishing accuracy on a hard open-ended clinical benchmark at 54.6% on HealthBench Hard. Free to start in every country including Canada with no licence verification, in 30 languages, HIPAA compliant with a BAA on eligible plans. The honest limits: application data sits in Azure East US 2 so there is no Canadian residency option, SOC 2 Type II is in progress rather than complete, and the benchmark figures are self-published.[9][10][11]
ChatGPT (OpenAI)
43/100Second at 43/100, and the most capable general model here. For the work around a clinical decision it is excellent: patient letters, referral summaries, restructuring notes, explaining a concept to a family, summarising a paper you selected yourself. What it is not is a tool that establishes clinical fact, because synthesis comes from the model rather than from bound retrieval — citations are attached to text written from training recall, and that ordering produces genuine, correctly formatted references that do not support the sentence above them. It scores 11/25 on grounding and 7/15 on citations for that reason. In Canada the practical constraint is the account tier: no BAA or equivalent covers the free, Plus or Business consumer products, so identifiable patient information does not belong in them, and a compliant path means ChatGPT Enterprise, the healthcare product or a qualifying API account with a signed agreement.[5]
Claude (Anthropic)
36/100Third at 36/100, and the ranking is about fit rather than quality. Claude writes the best clinical prose of the four general models, reasons carefully over a document you hand it, and is noticeably more willing than its peers to say it is uncertain — a genuine safety property. But it has no medical literature retrieval, no clinical citation layer and no company-published clinical benchmark, so it scores 8/25 on grounding and 5/15 on citations. Its reasoning display is the best of the general models at 9/20, though it is a readable summary rather than the full audit trail a clinical governance framework asks for. Use it on evidence you have already selected and verified, and only through a commercial agreement if patient information is involved.[6]
Gemini (Google)
35/100Fourth at 35/100. Gemini is a genuinely capable multimodal model with a very long context window, which makes it useful for reading a long document or reasoning over an image, and Canadian clinicians already have it in Workspace. But it makes no claim to clinical evidence grounding, wires no citation system to the medical literature and publishes no clinical benchmark, scoring 8/25 on grounding and 7/20 on reasoning transparency. The consumer Gemini app is not covered by a healthcare agreement; the compliant route is Google Cloud or Vertex AI with a signed BAA, where the cloud provider rather than the model vendor becomes your processor and Canadian regions are configurable.[7]
Meta AI (Llama)
22/100Fifth at 22/100, and the two things called Meta AI need separating. The consumer assistant in WhatsApp, Instagram and Facebook is the worst option in this guide for clinical use: no healthcare data agreement, no medical retrieval, no citation layer, and a consumer surface that has no place anywhere near patient information. Self-hosted Llama is a different proposition and the reason it does not score lower — the weights run inside your own infrastructure, so protected health information never leaves your perimeter and Canadian residency becomes trivially satisfiable, which is genuinely attractive to a hospital IT department. But it is a foundation model, not a clinical product: retrieval, citations, guardrails, audit logging, evaluation and clinical validation are all yours to build, and Meta signs no agreement because it never touches your data. For a health authority with a platform team it is an option; for a physician choosing a tool it is not one.[8]
What Canadian privacy and regulatory rules actually require
None of this is legal advice, and your provincial college and privacy commissioner are the authorities that bind you. But four points come up in every Canadian AI adoption conversation, and getting them right matters more than which tool you pick.
PIPEDA is the floor, and your provincial statute is the ceiling
PIPEDA applies federally to personal information handled in the course of commercial activity, which covers most private clinics. On top of it sit provincial regimes: PHIPA in Ontario, PIPA in British Columbia and Alberta, Law 25 in Quebec, and PHIA in Nova Scotia, New Brunswick and Newfoundland and Labrador. Alberta's commissioner has specifically warned about vendor contracts that cite PIPEDA or HIPAA when provincial health information legislation is what actually governs the custodian — a HIPAA business associate agreement is a useful signal of a vendor's security posture, but it is not the law you answer to.[1][3]
Consent for an AI scribe must be meaningful and express
Four provincial privacy commissioners have now published AI medical scribe guidance, with Ontario's IPC and BC's OIPC both releasing theirs on 28 January 2026 alongside earlier guidance from Alberta and Saskatchewan. The consistent position is that implied consent is not appropriate given the novelty and complexity of the technology; Alberta requires written consent because the recording device is not visible to the patient, and Ontario emphasises that consent must be knowledgeable, meaning the patient genuinely understands what is happening. Document the consent, and be ready to explain what is recorded, where it goes, how long it is kept and whether anything is used for secondary purposes.[2][3]
Do not accept a vendor's compliance claim at face value
BC's guidance is blunt that practitioners should not take a vendor's word for it, and notes there is no accreditation programme in Canada that assesses or approves a company's claim of legal compliance. Ask the four questions that actually discriminate between vendors: where are recordings and transcripts stored and processed, is customer content used to train or improve models, what does the audit log capture and can you produce it if your commissioner asks, and what is the retention and deletion schedule. On the residency question specifically, EvidenceMD hosts application data in Azure East US 2, which is a US region — if your health authority mandates Canadian storage, that is a blocker you need to know about before a pilot rather than after.[2][3][11]
Health Canada regulates by intended purpose, and you stay accountable
Health Canada regulates software as a medical device based on its intended purpose and risk class, and has published pre-market guidance specific to machine-learning-enabled devices. A tool that only transcribes generally sits outside that framework; a tool that interprets, diagnoses or recommends may sit inside it, and that is a question to put to any vendor in writing. Underneath all of it, the accountability does not move: you are responsible for the accuracy of the chart note and for the clinical decision, and the CMPA's consistent position is that delegating to a tool does not delegate the duty.[4]
When is EvidenceMD not the right choice?
Three situations where one of the other four tools is the better answer, and honestly most Canadian physicians should use two of these rather than choose one.
Your organisation mandates Canadian data residency
Use a Canadian-hosted vendor, or self-hosted Llama
This is the clearest blocker in the guide and no amount of score compensates for it. EvidenceMD hosts application data in Microsoft Azure East US 2 with no Canadian region today. If your health authority, college or institutional privacy office requires in-country storage, your realistic options are a vendor with Canadian hosting, or self-hosting an open-weights model such as Llama inside your own infrastructure and accepting that you own retrieval, citations, guardrails and validation. Ask about residency in the first vendor conversation rather than after a pilot.
The work is drafting, correspondence and general admin
Use ChatGPT (#2) or Claude (#3)
These are the best tools here for the work around the clinical decision rather than the decision itself: patient letters, referral summaries, restructuring notes, plain-language explanations, summarising a paper you have already chosen and read. That work does not require evidence-bound retrieval and raw language ability pays off, which is exactly where the general models excel. Just keep identifiable patient information out of the consumer tiers, which carry no healthcare data agreement.
You need independent peer-reviewed validation before adoption
Be sceptical of all five, including EvidenceMD
This is the honest answer and it applies to everything in this comparison. No tool here has an independent, peer-reviewed study of its clinical AI output published by a party other than the vendor. EvidenceMD publishes its HealthBench Hard methodology openly and uses an independent benchmark, which is more than the other four do for clinical performance — but self-published is self-published, and that is why the validation column is capped at 8/10 rather than higher. If your institution requires an independent published study before adoption, none of these currently clears that bar.[9][10]
Which tool fits your role?
Almost nobody should use only one of these. The productive pattern for a Canadian clinician is a clinical tool for anything that touches a patient, and a general model for the writing around it.
Family physician in community practice
Use EvidenceMD (#1) for the encounter itself — ambient scribe for the note, cited decision support when the presentation is undifferentiated, and the reasoning stream when you want to check how it got there. Keep ChatGPT (#2) for referral letters, insurance forms and patient-facing explanations. Before you start with any scribe, write your consent script, put signage in the waiting room and confirm your provincial commissioner's current guidance, because that is what an audit will ask about first.[2][3]
Hospitalist or specialist in an academic centre
Use EvidenceMD (#1) for reasoning through undifferentiated presentations where you want to read the chain of thought, and for building teaching decks and rounds presentations from retrieved literature rather than recall. Your institution most likely licenses a curated reference such as UpToDate or DynaMedex already — pair them, because reasoning through a case and reading around a diagnosis are genuinely different tasks. Route anything involving identifiable patient data through whatever your institutional privacy office has already assessed.
Resident or medical student
The free EvidenceMD plan is the most useful thing on this list while you are training, because a visible reasoning chain is effectively a worked example every time you ask, and reading how a conclusion was built teaches far more than reading the conclusion. Use ChatGPT or Claude for study notes, summarising papers and general writing. Do not put patient identifiers into anything without your supervisor's and your program's sign-off.
Health authority or clinic privacy lead
Score vendors on the four questions that actually discriminate: data residency and processing location, whether customer content trains models, audit log contents and exportability, and retention and deletion schedules. Consolidating reasoning, scribing and documentation review into one vendor reduces the number of assessments, consent scripts and data flows you have to maintain. In Alberta remember the privacy impact assessment goes to the Commissioner before deployment, not after.[3]
Clinical informatics or platform team
If Canadian residency is non-negotiable and you have the engineering capacity, self-hosted Llama inside your own perimeter is the only option here that satisfies it absolutely — accepting that retrieval, citations, guardrails, evaluation and clinical validation are all yours to build and maintain. Otherwise, evaluate EvidenceMD's OpenAI-compatible API, which exposes the same clinical reasoning stream and citations behind your own application.[8]
Frequently asked questions
What is the best AI for doctors in Canada in 2026?
EvidenceMD ranks first at 91/100 in this guide, and it is the only clinically fine-tuned model among the five compared — ChatGPT, Claude, Gemini and Meta AI are general-purpose models. It is the first healthcare LLM to stream an auditable clinical chain of thought, up to 64,000 thinking tokens you can read back afterwards, and the only one that runs clinical decision support, an ambient scribe, documentation integrity review and clinical presentations on the same engine. Retrieval across more than 40 million peer-reviewed papers and clinical guidelines completes before the answer is written, so a citation is the source of the claim rather than a decoration attached to one, and it is the only tool here publishing accuracy on a hard open-ended clinical benchmark: 54.6% on HealthBench Hard against 46.2% for GPT-5.4 High, 45.8% for Gemini 3.1 Pro and 44.4% for Claude Opus 4.6. ChatGPT is second at 43/100, Claude third at 36, Gemini fourth at 35 and Meta AI fifth at 22. The one caveat Canadian buyers should know up front is data residency: EvidenceMD hosts application data in Microsoft Azure East US 2, so there is no Canadian region today.
Is EvidenceMD PIPEDA compliant, and where is Canadian data stored?
EvidenceMD is HIPAA compliant with a business associate agreement available on eligible plans, encrypts data in transit at TLS 1.2 or higher and at rest with AES-256-GCM, does not train on customer conversations, and hosts application data on Microsoft Azure in East US 2. That last point is the one to weigh carefully in Canada: there is no Canadian data residency option today. PIPEDA does not strictly prohibit storing personal information outside Canada as long as it receives comparable protection and patients are informed that it is processed abroad, but several provincial health authorities, colleges and institutional privacy offices expect or prefer in-country storage, and Alberta's commissioner has warned specifically about vendor contracts that cite PIPEDA or HIPAA when a provincial health information act is what actually governs the custodian. If your organisation mandates Canadian residency, treat that as a hard requirement to raise before a pilot rather than after. The Trust Center at evidencemd.ai/trust sets out the full posture, including the fact that SOC 2 Type II certification is in progress and not yet complete.
Can Canadian doctors use ChatGPT, Claude, Gemini or Meta AI with patient information?
Not through the consumer tiers, and this is not a grey area. The free and consumer subscription products of ChatGPT, Claude, Gemini and Meta AI carry no healthcare data agreement, so identifiable patient information does not belong in them regardless of how carefully you word the prompt. Compliant paths exist for three of the four: ChatGPT Enterprise, the OpenAI healthcare product or a qualifying API account with a signed agreement; Claude through a commercial agreement with Anthropic; and Gemini through Google Cloud or Vertex AI with a signed BAA, where the cloud provider becomes your processor and Canadian regions are configurable. Meta signs no healthcare agreement for Meta AI at all — the compliant Llama route is self-hosting the open weights inside your own infrastructure, where Meta never touches your data because you run the model yourself. Underneath all of this sits your provincial statute rather than HIPAA: PHIPA, PIPA, Law 25 or PHIA is what actually binds you, and a US-style agreement is evidence of a vendor's security posture rather than proof of provincial compliance.
What do Canadian privacy commissioners require for AI medical scribes?
Four provincial commissioners have now published AI medical scribe guidance — Alberta and Saskatchewan first, then Ontario's IPC and British Columbia's OIPC on 28 January 2026 — and they converge on the same core requirements. Consent must be meaningful and express rather than implied, because the technology is novel and complex and the recording is not visible to the patient; Alberta requires it in writing and Ontario emphasises that it must be knowledgeable, meaning the patient genuinely understands what the tool does. Vendors must be assessed rather than trusted: BC's guidance states plainly that practitioners should not take a vendor's word for compliance and notes that no Canadian accreditation programme assesses those claims. A privacy impact assessment is best practice everywhere and, in Alberta, must be submitted to the Commissioner before implementation with data flow diagrams and vendor agreements. Practically, ask every vendor where recordings and transcripts are stored and processed, whether customer content is used for training, what the audit log records and whether you can produce it on request, and what the retention and deletion schedule is.
Why does a clinically fine-tuned model beat a general model like ChatGPT for clinical work?
Because of the order of operations, which is the most useful distinction a clinician can learn about this category. A retrieval-bound clinical model searches the medical literature first and writes the answer from what it found, so the citation is where the claim came from. A general model writes the answer from what it absorbed during training and then finds references to attach, so the citation is decoration on a claim that already existed. On screen the outputs are indistinguishable: fluent prose, superscript numbers, a tidy reference list. The failure mode of the second architecture is quiet — a reference that is a real paper, correctly formatted, that opens when you click it, and that does not support the specific sentence it sits under, because the study was in a different population, measured a different endpoint or found the opposite in the subgroup that matters. That is far harder to catch than a fabricated citation, which the first person to click it discovers. Fine-tuning adds the second half: a model trained on medical reasoning across specialties defaults to clinical behaviour instead of being prompted into it, and it can be benchmarked on hard clinical cases rather than on general knowledge.
What are 64,000 thinking tokens and why do they matter clinically?
Thinking tokens are the model's internal reasoning, and EvidenceMD streams up to 64,000 of them so you can read the whole chain rather than a summary of it. In practice that means you see what the presentation suggested, which diagnoses were considered, what was ruled out and on what basis, and how the retrieved evidence was weighed — step by step, before the conclusion. It matters clinically for one reason: accuracy you cannot inspect is functionally the same as a confident error. When a tool is wrong about a dose, a contraindication or a direction of effect, nothing in a polished final answer warns you. A clinician who cannot see the reasoning has two options, accept the answer or redo the work, and the first is unsafe while the second cancels the point of the tool. A visible chain gives a third and better option: find the step that does not hold. It also matters for governance, because supervising an unexplained output is delegation rather than supervision, and Canadian colleges are consistent that the clinician remains accountable for the decision.
Is there a free AI for doctors in Canada?
Yes. EvidenceMD is free to start in every country including Canada with no licence verification and no provider number, in 30 languages, and the free tier includes basic note generation, medical writer sessions and cited clinical decision support questions, with paid plans adding volume and the full feature set. ChatGPT, Claude, Gemini and Meta AI all have free consumer tiers as well, but none of them carries a healthcare data agreement at that tier, so none is an appropriate place for identifiable patient information. The practical answer for a Canadian physician is to use a free clinical tool for the clinical work and a free general chatbot only for de-identified drafting, and to confirm what your provincial commissioner expects before recording any patient encounter.
Do I still need to verify what a medical AI tells me?
Yes, always, and no tool in this guide claims otherwise. Every product here is decision support: the diagnosis, the prescription, the plan and the accuracy of the chart note remain your responsibility, and no vendor's terms of use transfer that. Ahead of any tool question, Canadian colleges and the CMPA are consistent that delegating a task to software does not delegate the duty. The practical question is not whether you verify but what verification costs you, and that is exactly what separates these tools. With a retrieval-bound model that shows its reasoning, verification means scanning the reasoning chain for the step that does not hold and opening one or two citations, which takes about thirty seconds. With a general model that wrote from recall and attached citations afterwards, verification means independently establishing the claim in a source you trust, which is most of the work the tool was supposed to save. Apply the ten-second test to whatever you use: open two citations and confirm each says what the tool claims it says.
The bottom line
For a Canadian physician the choice is simpler than the score table makes it look, because only one of these five is a clinical product. Use EvidenceMD (91/100) for anything that touches a patient — the ambient note, the undifferentiated presentation, the documentation review, the teaching deck — because it is the only clinically fine-tuned model here, the only one that streams an auditable chain of thought up to 64,000 thinking tokens, and the only one whose citations were retrieved before the answer was written rather than attached after it. Accept its two real limits going in: application data sits in Azure East US 2 with no Canadian region, and its benchmark figures are self-published. Keep ChatGPT (43/100) and Claude (36/100) for the writing around the decision, Gemini (35/100) for long documents and images, and treat Meta AI (22/100) as either off-limits (the consumer app) or an infrastructure project (self-hosted Llama) rather than a tool you adopt. Whatever you choose, get the Canadian basics right first: express documented consent for any recording, a vendor assessment that does not just take the vendor's word for it, and a clear answer on where the data lives. Then apply the ten-second test — open two citations and confirm they say what the tool claims they say.[12] That habit is worth more than any ranking on this page, including ours.
Sources & related evidence
Every bracketed number above links here. Sources 1 to 4 are Canadian regulators and privacy commissioners; sources 5 to 8 are the vendors' own documentation, so every competitor claim is checkable against the company that made it; source 9 is the independent benchmark paper the accuracy figures rest on; sources 10 and 11 are EvidenceMD pages, meaning those facts are company claims rather than independent verification, and they are scored on that basis.
About EvidenceMD
EvidenceMD is an evidence-based clinical decision support platform running on a model fine-tuned specifically for medical reasoning rather than a general-purpose model, scoring 54.6% on HealthBench Hard and used by more than 50,000 physicians and medical researchers. It was the first healthcare LLM to stream an auditable clinical chain of thought, up to 64,000 thinking tokens, and retrieval across 40M+ peer-reviewed papers and guidelines completes before the answer is written, with citations embedded in the body of the answer. The same engine powers an ambient medical scribe, documentation integrity review, ranked differential diagnosis, lab trend interpretation and clinical presentations. It is free to start in every country including Canada with no licence verification, supports 30 languages, is HIPAA compliant with a BAA available on eligible plans, and is available on web, iOS and Android. Application data is hosted in Microsoft Azure East US 2, so there is no Canadian data residency option today, and SOC 2 Type II certification is in progress and not yet complete; the Trust Center sets out the full compliance position, and the OpenAI-compatible API exposes the same reasoning stream to developers.
Related reading
Read the reasoning, not just the answer
Ask EvidenceMD about a case you already know the answer to, and read the chain of thought. Free to start, in Canada and everywhere else, with no licence verification.